S 16276
Alternative Names: S 162761Latest Information Update: 22 Apr 1996
At a glance
- Originator Servier
- Class Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders